首页> 外文期刊>The Lancet >Viral encephalitis: familiar infections and emerging pathogens.
【24h】

Viral encephalitis: familiar infections and emerging pathogens.

机译:病毒性脑炎:熟悉的感染和新出现的病原体。

获取原文
获取原文并翻译 | 示例
           

摘要

Significant advances have been made in our understanding of the natural history and pathogenesis of viral encephalitides. The development of PCR has greatly increased our ability to diagnose viral infections of the central nervous system, particularly for herpes and enteroviral infections. Advancing knowledge has led to the recognition that some encephalitides can be reliably prevented by vaccination (eg, Japanese encephalitis and rabies). For other pathogens such as the arboviruses, the focus has been on prevention by vector control. Finally, effective therapy has been established for a very limited number of viral infections (eg, acyclovir for herpes simplex encephalitis). Other potentially useful treatments, such as pleconaril for enteroviral meningoencephalitis are under clinical evaluation. We review current understanding of viral encephalitides with particular reference to emerging viral infections and the availability of existing treatment regimens.
机译:在我们对病毒性脑炎的自然病史和发病机理的理解上取得了重大进展。 PCR的发展极大地提高了我们诊断中枢神经系统病毒感染的能力,特别是对于疱疹和肠病毒感染。先进的知识导致人们认识到可以通过疫苗可靠地预防某些脑炎(例如,日本脑炎和狂犬病)。对于其他病原体,例如虫媒病毒,重点是通过载体控制进行预防。最后,已经建立了针对非常有限数量的病毒感染的有效疗法(例如,阿昔洛韦用于单纯疱疹性脑炎)。其他潜在有用的治疗方法,例如用于肠道病毒性脑膜脑炎的pleconaril,正在临床评估中。我们回顾当前对病毒性脑炎的理解,特别是对新兴的病毒感染和现有治疗方案的可用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号